Investigation through naphtho[2,3‐a]pyrene on mutated EGFR mediated autophagy in NSCLC : Cellular model system unleashing therapeutic potential
IUBMB Life · 2024
DOI: 10.1002/iub.2914 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, 2024. Verfasst von Nikhil Samarth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Systems Medicine Laboratory, Biotechnology Research and Innovation Council-National Centre for Cell Science (BRIC-NCCS), NCCS Complex, Pune, India. Hauptthemen laut MEDLINE: ErbB Receptors, Autophagy, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Mutant epidermal growth factor receptor (EGFR) signaling has emerged as a key cause of carcinogenesis and therapy resistance in non‐small cell lung cancer (NSCLC), which continues to pose a serious threat to world health. In this study, we aimed to elucidate the complex molecular pathways of EGFR‐mediated autophagy signaling in NSCLC. We identified naphtho[2,3‐a]pyrene, an anthraquinolone derivative, to be a promising investigational drug that targets EGFR‐mediated autophagy using a cellular model system. By utilizing systems biology, we developed a computational model that explained the signaling of EGFR‐mediated autophagy and identified critical crosstalk sites that could be inhibited therapeutically. As a lead compound, naphtho[2,3‐a]pyrene was confirmed by molecular docking experiments. It was found to be cytotoxic to NSCLC cells, impact migration, induce apoptosis, and arrest cell cycle, both on its own and when combined with standard drugs. The anticancer efficacy of naphtho[2,3‐a]pyrene was validated in vivo on CDX nude mice. It showed synergistic activity against NSCLC when coupled with gefitinib, chloroquine, and radiation. Altogether, our study highlights naphtho[2,3‐a]pyrene's therapeutic promise in NSCLC by focusing on EGFR‐mediated autophagy and providing a new strategy to fight drug resistance and tumor survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Systems Medicine Laboratory, Biotechnology Research and Innovation Council-National Centre for Cell Science (BRIC-NCCS), NCCS Complex, Pune, India.
ORCID-Profile: Shailza Singh
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Samarth, N., Gulhane, P., & Singh, S. (2024). Investigation through naphtho[2,3‐a]pyrene on mutated EGFR mediated autophagy in NSCLC : Cellular model system unleashing therapeutic potential. IUBMB Life. https://doi.org/10.1002/iub.2914
Vancouver
Samarth N, Gulhane P, Singh S. Investigation through naphtho[2,3‐a]pyrene on mutated EGFR mediated autophagy in NSCLC : Cellular model system unleashing therapeutic potential. IUBMB Life. 2024. doi:10.1002/iub.2914
BibTeX
@article{Samarth2024,
author = {Samarth, Nikhil and Gulhane, Pooja and Singh, Shailza},
title = {Investigation through naphtho[2,3‐a]pyrene on mutated EGFR mediated autophagy in NSCLC : Cellular model system unleashing therapeutic potential},
journal = {IUBMB Life},
year = {2024},
doi = {10.1002/iub.2914}
}
EUVIMED